Foresite Capital Management Ii, LLC 10x Genomics, Inc. Transaction History

Foresite Capital Management Ii, LLC

  • $29.2 Million
  • Q3 2023

A detailed history of Foresite Capital Management Ii, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Foresite Capital Management Ii, LLC holds 708,528 shares of TXG stock, worth $11.2 Million. This represents 100.0% of its overall portfolio holdings.

Number of Shares
708,528
Previous 708,528 -0.0%
Holding current value
$11.2 Million
Previous $39.6 Million 26.13%
% of portfolio
100.0%
Previous 100.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
SELL
$35.33 - $55.79 $23 Million - $36.3 Million
-650,000 Reduced 47.85%
708,528 $39.5 Million
Q4 2022

Feb 13, 2023
SELL
$24.4 - $41.3 $9.64 Million - $16.3 Million
-395,000 Reduced 22.53%
1,358,528 $49.5 Million
Q2 2021

Aug 16, 2021
SELL
$134.22 - $202.37 $67.1 Million - $101 Million
-500,000 Reduced 22.19%
1,753,528 $343 Million
Q1 2021

May 17, 2021
SELL
$140.25 - $196.86 $35.1 Million - $49.2 Million
-250,000 Reduced 9.99%
2,253,528 $408 Million
Q4 2020

Feb 16, 2021
SELL
$126.47 - $163.7 $126 Million - $164 Million
-1,000,000 Reduced 28.54%
2,503,528 $355 Million
Q3 2020

Nov 13, 2020
SELL
$87.44 - $125.0 $175 Million - $250 Million
-2,000,000 Reduced 36.34%
3,503,528 $437 Million
Q2 2020

Aug 13, 2020
SELL
$58.39 - $89.31 $63.3 Million - $96.8 Million
-1,083,725 Reduced 16.45%
5,503,528 $492 Million
Q1 2020

May 14, 2020
SELL
$51.57 - $106.62 $12.9 Million - $26.7 Million
-250,000 Reduced 3.66%
6,587,253 $411 Million
Q3 2019

Nov 13, 2019
BUY
$49.99 - $62.0 $342 Million - $424 Million
6,837,253 New
6,837,253 $345 Million

Others Institutions Holding TXG

# of Institutions
291
Shares Held
94.7M
Call Options Held
263K
Put Options Held
85.1K
View Full List

About 10x Genomics, Inc.

TXG Quotes by TradingView
  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Foresite Capital Management Ii, LLC Portfolio

Follow Foresite Capital Management Ii, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foresite Capital Management Ii, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foresite Capital Management Ii, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email